Marc Mazur Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Mazur SSSS stock SEC Form 4 insiders trading

Marc has made over 2 trades of the Sutter Rock Capital stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of SSSS stock worth $26,700 on 14 August 2017.

The largest trade he's ever made was buying 6,000 units of Sutter Rock Capital stock on 14 August 2017 worth over $26,700. On average, Marc trades about 647 units every 69 days since 2012. As of 14 August 2017 he still owns at least 6,000 units of Sutter Rock Capital stock.

You can see the complete history of Mr. Mazur stock trades at the bottom of the page.

Marc Mazur biography

Marc Mazur serves as Independent Director of the Company. He has served as a member of our Board of Directors since March 2017. Mr. Mazur has served as an Industry Advisor to Brightwood Capital Advisors, LLC, a private debt fund, since 2014 and served as a member of the board of directors for Fibrocell Science, Inc. (NASDAQ: FCSC), an autologous cell and gene therapy company, from April 2010 to December 2019. Mr. Mazur previously served as the Chief Executive Officer of Brevan Howard U.S. Asset Management, a London-based global macro hedge fund, and as a senior advisor of such company until 2010. He also previously served as a senior advisor to Tsinghua Venture Capital Company. Mr. Mazur served in management roles at Salomon Brothers, Inc., The Goldman Sachs Group, Inc. from 1987 until 1996, and served as a consultant for Goldman from 1997 to 1999. He was an executive with Careinsite/Medical Manager and has served as a director of Staywell Health, DeVilbiss Healthcare, ChanceLight Behavioral Health and other private companies in the wellness, addiction treatment, homecare and medical device fields. Mr. Mazur received his B.A. in Political Science from Columbia University and a J.D. from Villanova University School of Law

How old is Marc Mazur?

Marc Mazur is 60, he's been the Independent Director of Sutter Rock Capital since 2017. There are no older and 9 younger executives at Sutter Rock Capital.

What's Marc Mazur's mailing address?

Marc's mailing address filed with the SEC is C/O SURO CAPITAL CORP., 640 FIFTH AVENUE, 12TH FLOOR, NEW YORK, NY, 10019.

Insiders trading at Sutter Rock Capital

Over the last 5 years, insiders at Sutter Rock Capital have traded over $13,527,804 worth of Sutter Rock Capital stock and bought 1,897,330 units worth $12,344,628 . The most active insiders traders include Robert S. Birch, Mark D Klein и Leonard Potter. On average, Sutter Rock Capital executives and independent directors trade stock every 34 days with the average trade being worth of $215,925. The most recent stock trade was executed by Mark D Klein on 20 August 2024, trading 12,000 units of SSSS stock currently worth $46,080.

What does Sutter Rock Capital do?

SuRo Capital Corp. is a business development company. The firm seeks to invest in growing, late stage, venture capital-backed private companies. SuRo Capital Corp. was founded in 2010 and is based in San Francisco, California.

Sutter Rock Capital executives and stock owners

Sutter Rock Capital executives and other stock owners filed with the SEC include:

• Mark Klein,
  President, Chief Executive Officer, Lead Director
• Mark David Klein,
  Chairman, Pres & CEO
• Allison Green,
  Chief Financial Officer, Chief Compliance Officer, Treasurer, Corporate Secretary
• Allison Green CPA,
  CFO, Treasurer, Chief Compliance Officer & Corp. Sec.
• Allison Green C.P.A.,
  CFO, Treasurer, Chief Compliance Officer & Corp. Sec.
• Leonard Potter,
  Independent Director
• Marc Mazur,
  Independent Director
• Ronald Lott,
  Independent Director
• Lisa Westley,
  Director
• Keri Findley,
  Senior Managing Director
• Henry Emanuel,
  Investor
• Maulik Sardhara,
  Controller
• Sandra Linn,
  Investor Relation
• William Lee,
  Investor
• Claire Councill,
  Investor
• Keri Findley,
  Sr. Managing Director
• Jackson Stone,
  Investment Associate
• Matthew Hanson,
  Investment Professional
• Adam Bates,
  Investor
• Nicholas Franco,
  VP
• Tim Chau,
  Controller
• Kerry Wang,
  VP of Fin. & Controller
• Robert S. Birch,